Clinical outcome with correlation to disseminated tumor cell (DTC) status after DTC-guided secondary adjuvant treatment with docetaxel in early breast cancer. [electronic resource]
Producer: 20150212Description: 3848-57 p. digitalISSN:- 1527-7755
- Antineoplastic Agents, Phytogenic -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Bone Marrow Cells -- chemistry
- Breast Neoplasms -- chemistry
- Chemotherapy, Adjuvant
- Chi-Square Distribution
- Cyclophosphamide -- administration & dosage
- Disease-Free Survival
- Docetaxel
- Drug Administration Schedule
- Epirubicin -- administration & dosage
- Female
- Fluorouracil -- administration & dosage
- Humans
- Immunohistochemistry
- Infusions, Intravenous
- Kaplan-Meier Estimate
- Keratins -- analysis
- Ki-67 Antigen -- analysis
- Middle Aged
- Neoplastic Cells, Circulating -- chemistry
- Norway
- Predictive Value of Tests
- Proportional Hazards Models
- Prospective Studies
- Retreatment
- Risk Factors
- Taxoids -- administration & dosage
- Time Factors
- Treatment Failure
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Webcast
There are no comments on this title.
Log in to your account to post a comment.